skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8838

An “acquired” hemoglobin J variant in a sickle cell disease patient

Case report

(2676) Views  (762) Full article downloads

Authors: Nawwar Swedan, Kathleen Nicol, Phylis Moder, Samir Kahwash

Published Date June 2008 Volume 2008:4(3) Pages 649 - 652
DOI: http://dx.doi.org/10.2147/TCRM.S6866

Nawwar Swedan1, Kathleen Nicol2, Phylis Moder2, Samir Kahwash2

1Fellow in Transfusion Medicine, Ohio State University, Columbus, Ohio; 2Department of Laboratory Medicine, Nationwide Children’s Hospital, Columbus, Ohio

Abstract: We report the case of a rare hemoglobin variant, “Hemoglobin J”, discovered while performing hemoglobin electrophoresis following exchange transfusion of a sickle cell disease patient. It is usual practice in our institution to confirm the hemoglobin S level in sickle cell disease patients after red cell exchange. The patient had received 5 red cell units and the source of this variant was traced back to two of those units. Due to the uncertain clinical impact of this variant, and the lack of specific guidelines, the two donors were deferred from future donations to our institution.

Keywords: hemoglobin J, sickle cell disease, transfusion








Readers of this article also read:

A review of topotecan in combination chemotherapy for advanced cervical cancer
Cost-effectiveness analysis of electrochemotherapy with the Cliniporator™ vs other methods for the control and treatment of cutaneous and subcutaneous tumors
Towards a new standard of perioperative fluid management
Moderate and severe plaque psoriasis: cost-of-illness study in Italy
Nonlinear analysis of the heartbeats in public patient ECGs using an automated PD2i algorithm for risk stratification of arrhythmic death
Antiviral treatment in patients with hepatitis C virus-related cirrhosis awaiting liver transplantation
Treatment strategies in mucous membrane pemphigoid
Efficacy of deoxyspergualine for antibody-mediated rejection and proteinuria after kidney transplantation
The use of fondaparinux for the treatment of venous thromboembolism in a patient with heparin-induced thombocytopenia and thrombosis caused by heparin flushes
Concurrent Chagas’ disease and borderline disseminated cutaneous leishmaniasis: The role of amiodarone as an antitrypanosomatidae drug